🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anthony M. Joshua

St Vincent's Hospital Sydney

ORCID: 0000-0001-5159-4580

Also affiliated with The Kinghorn Cancer Centre

Materials ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial”.

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00757-9
N/A
4.9DataRank · unranked
188 citations

Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara, Evan Y Yu +90 more

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.010
N/A
3.9DataRank · unranked
100 citations

Wen-Jen Hwu, Omid Hamid, Antoni Ribas, Jeffrey S. Weber, Adil Daud +18 more

Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer

BMC Medicine(2022)10.1186/s12916-022-02298-0
N/A
0DataRank · unranked
21 citations

Hui‐Ming Lin, Edmond M. Kwan, Heidi Fettke, Ben Tran, Ian D. Davis +22 more

1616P Circulating tumour DNA (ctDNA) measurements and PET-imaging to evaluate response in a phase Ib trial of metastatic castration-resistant prostate cancer (mCRPC) treated with Lutetium-177-PSMA-617 (LuPSMA) plus pembrolizumab (PRINCE)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1697
N/A
0DataRank · unranked
3 citations

Emily Kwan, S.W.S. Ng, Anthony M. Joshua, L. Emmett, Megan Crumbaker +15 more

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants

European Urology Focus(2025)10.1016/j.euf.2025.03.017
N/A
0DataRank · unranked
3 citations

Shivakumar Keerthikumar, Scott L. Townley, Ashlee K. Clark, Georgia B. Cuffe, Geraldine Laven‐Law +17 more